1011. KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: implication for combinatorial approach.
Yoon YK, Kim HP, Han SW, Oh do Y, Im SA, Bang YJ, Kim TY.
1008. Gq protein mediates UVB-induced cyclooxygenase-2 expression by stimulating HB-EGF secretion from HaCaT human keratinocytes.
Seo M, Juhnn YS.
Biochem Biophys Res Commun. 2010 Mar 5;393(2):190-5.Link
1007. Clinical Outcomes of Sorafenib Treatment in Patients With Metastatic Hepatocellular Carcinoma Who Had Been Previously Treated With Fluoropyrimidine Plus Platinum-based Chemotherapy.
Kim JW, Lee JO, Han SW, Oh DY, Im SA, Kim TY, Bang YJ.
1005. Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling.
1003. Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.
Han SW, Oh DY, Im SA, Park SR, Lee KW, Song HS, Lee NS, Lee KH, Choi IS, Lee MH, Kim MA, Kim WH, Bang YJ, Kim TY.
1002. Wild-type p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer model.
Lee YJ, Chung JK, Kang JH, Jeong JM, Lee DS, Lee MC.
Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):235-41.Link